140 related articles for article (PubMed ID: 30597051)
21. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.
Bayarsaikhan O; Kawai N; Mori H; Kinouchi N; Nikawa T; Tanaka E
J Nutr Sci Vitaminol (Tokyo); 2017; 63(4):244-248. PubMed ID: 28978871
[TBL] [Abstract][Full Text] [Related]
22. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.
Amthor H; Hoogaars WM
Curr Gene Ther; 2012 Jun; 12(3):245-59. PubMed ID: 22554312
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro investigations of heterozygous nebulin knock-out mice disclose a mild skeletal muscle phenotype.
Gineste C; De Winter JM; Kohl C; Witt CC; Giannesini B; Brohm K; Le Fur Y; Gretz N; Vilmen C; Pecchi E; Jubeau M; Cozzone PJ; Stienen GJ; Granzier H; Labeit S; Ottenheijm CA; Bendahan D; Gondin J
Neuromuscul Disord; 2013 Apr; 23(4):357-69. PubMed ID: 23375831
[TBL] [Abstract][Full Text] [Related]
24. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.
Koncarevic A; Cornwall-Brady M; Pullen A; Davies M; Sako D; Liu J; Kumar R; Tomkinson K; Baker T; Umiker B; Monnell T; Grinberg AV; Liharska K; Underwood KW; Ucran JA; Howard E; Barberio J; Spaits M; Pearsall S; Seehra J; Lachey J
Endocrinology; 2010 Sep; 151(9):4289-300. PubMed ID: 20573726
[TBL] [Abstract][Full Text] [Related]
25. Electrical impedance myography as a biomarker of myostatin inhibition with ActRIIB-mFc: a study in wild-type mice.
Nagy JA; Kapur K; Taylor RS; Sanchez B; Rutkove SB
Future Sci OA; 2018 Jul; 4(6):FSO308. PubMed ID: 30057785
[TBL] [Abstract][Full Text] [Related]
26. Nebulin expression in patients with nemaline myopathy.
Gurgel-Giannetti J; Reed U; Bang ML; Pelin K; Donner K; Marie SK; Carvalho M; Fireman MA; Zanoteli E; Oliveira AS; Zatz M; Wallgren-Pettersson C; Labeit S; Vainzof M
Neuromuscul Disord; 2001 Mar; 11(2):154-62. PubMed ID: 11257471
[TBL] [Abstract][Full Text] [Related]
27. Nebulin stiffens the thin filament and augments cross-bridge interaction in skeletal muscle.
Kiss B; Lee EJ; Ma W; Li FW; Tonino P; Mijailovich SM; Irving TC; Granzier HL
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10369-10374. PubMed ID: 30249654
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy.
Nguyen MA; Joya JE; Kee AJ; Domazetovska A; Yang N; Hook JW; Lemckert FA; Kettle E; Valova VA; Robinson PJ; North KN; Gunning PW; Mitchell CA; Hardeman EC
Brain; 2011 Dec; 134(Pt 12):3516-29. PubMed ID: 22067542
[TBL] [Abstract][Full Text] [Related]
29. Nemaline myopathy type 2 (NEM2): two novel mutations in the nebulin (NEB) gene.
Gajda A; Horváth E; Hortobágyi T; Gergev G; Szabó H; Farkas K; Nagy N; Széll M; Sztriha L
J Child Neurol; 2015 Apr; 30(5):627-30. PubMed ID: 24056153
[TBL] [Abstract][Full Text] [Related]
30. The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques.
O'Connell KE; Guo W; Serra C; Beck M; Wachtman L; Hoggatt A; Xia D; Pearson C; Knight H; O'Connell M; Miller AD; Westmoreland SV; Bhasin S
FASEB J; 2015 Apr; 29(4):1165-75. PubMed ID: 25466897
[TBL] [Abstract][Full Text] [Related]
31. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E171-82. PubMed ID: 23695214
[TBL] [Abstract][Full Text] [Related]
32. Nebulin, a major player in muscle health and disease.
Labeit S; Ottenheijm CA; Granzier H
FASEB J; 2011 Mar; 25(3):822-9. PubMed ID: 21115852
[TBL] [Abstract][Full Text] [Related]
33. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
Lee SJ; Reed LA; Davies MV; Girgenrath S; Goad ME; Tomkinson KN; Wright JF; Barker C; Ehrmantraut G; Holmstrom J; Trowell B; Gertz B; Jiang MS; Sebald SM; Matzuk M; Li E; Liang LF; Quattlebaum E; Stotish RL; Wolfman NM
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18117-22. PubMed ID: 16330774
[TBL] [Abstract][Full Text] [Related]
34. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential.
Han HQ; Zhou X; Mitch WE; Goldberg AL
Int J Biochem Cell Biol; 2013 Oct; 45(10):2333-47. PubMed ID: 23721881
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of myostatin reverses muscle fibrosis through apoptosis.
Bo Li Z; Zhang J; Wagner KR
J Cell Sci; 2012 Sep; 125(Pt 17):3957-65. PubMed ID: 22685331
[TBL] [Abstract][Full Text] [Related]
36. NEB-related core-rod myopathy with distinct clinical and pathological features.
Park YE; Shin JH; Kang B; Lee CH; Kim DS
Muscle Nerve; 2016 Mar; 53(3):479-84. PubMed ID: 26562614
[TBL] [Abstract][Full Text] [Related]
37. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
38. Distal myopathy caused by homozygous missense mutations in the nebulin gene.
Wallgren-Pettersson C; Lehtokari VL; Kalimo H; Paetau A; Nuutinen E; Hackman P; Sewry C; Pelin K; Udd B
Brain; 2007 Jun; 130(Pt 6):1465-76. PubMed ID: 17525139
[TBL] [Abstract][Full Text] [Related]
39. A patient with slowly progressive adult-onset nemaline myopathy and novel compound heterozygous mutations in the nebulin gene.
Tsunoda K; Yamashita T; Motokura E; Takahashi Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Nishikawa A; Nishino I; Abe K
J Neurol Sci; 2017 Feb; 373():254-257. PubMed ID: 28131200
[No Abstract] [Full Text] [Related]
40. Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism.
Joya JE; Kee AJ; Nair-Shalliker V; Ghoddusi M; Nguyen MA; Luther P; Hardeman EC
Hum Mol Genet; 2004 Nov; 13(21):2633-45. PubMed ID: 15367485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
